PuSH - Publikationsserver des Helmholtz Zentrums München

Cost-effectiveness of diagnostic interventions: Non-small cell lung cancer.

Onkologe 16, 992-1002 (2010)
DOI Verlagsversion bestellen
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The present article is intended as an introduction to health economic evaluation as well as a review of economic evaluations of positron emission tomography (PET and PET/CT) in the diagnosis and management of non-small cell lung cancer. Furthermore, the transferability of the results of economic evaluations in other countries to the German health care context is assessed. With the help of a literature search 13 full health economic evaluations of staging (12 studies) and follow-up (1 study) of non-small cell lung cancer were identified. The primary health benefit measure was life years gained or quality-adjusted life years gained. All of these evaluations were based on modeling studies. Due to differences in assumptions and methodological heterogeneity, the incremental cost-effectiveness ratios varied widely. Because of the complexity of the diagnostic and therapeutic process, the transferability of international study results to the German situation is limited. The cost-effectiveness of PET for other management decisions in non-small cell lung cancer (e.g. radiotherapy planning) is still to be assessed.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter 18F-Fluorodeoxyglucose; Positron-emission tomography; Computed tomography; Non-small cell lung cancer; Cost effectiveness; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; TECHNOLOGY-ASSESSMENT; PATIENT-MANAGEMENT; IMPACT; CARCINOMA; ONCOLOGY; RECOMMENDATIONS; ACCURACY; STRATEGY
ISSN (print) / ISBN 0947-8965
e-ISSN 1433-0415
Zeitschrift Onkologe, Der
Quellenangaben Band: 16, Heft: 10, Seiten: 992-1002 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort New York
Begutachtungsstatus